Sponsor:
Bayer
Code:
NCT04142437
Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
larotrectinib(Vitrakvi, BAY2757556)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-11. This information was provided to ClinicalTrials.gov by Bayer on 2025-04-10.